Diabetes and Its Impact on Cardiogenic Shock Outcomes in Acute Myocardial Infarction with Polyvascular Disease: A

Marlon V Gatuz1, Rami Abu-Fanne1, Dmitry Abramov2

  • 1Department of Cardiology, Hillel Yaffe Medical Center, Hadera 3200003, Israel.

Biomedicines
|August 29, 2024
PubMed

Insights

Diabetes mellitus (DM) increases mortality and adverse events in acute myocardial infarction (AMI) patients with cardiogenic shock (CS) and polyvascular disease. This highlights the need for targeted care in this high-risk group.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Medicine

Background:

  • Diabetes mellitus (DM) exacerbates cardiovascular risks, especially in acute myocardial infarction (AMI) with cardiogenic shock (CS).
  • Polyvascular disease further elevates prognosis challenges due to advanced atherosclerosis and comorbidities.
  • This study examines the combined effect of DM and polyvascular disease on AMI patients experiencing CS.

Purpose of the Study:

  • To investigate the impact of diabetes mellitus on outcomes in patients with acute myocardial infarction complicated by cardiogenic shock and polyvascular disease.
  • To analyze the association between diabetes status and in-hospital adverse events, mortality, and cerebrovascular accidents in this specific patient cohort.

Main Methods:

  • Analysis of 39,140 patients with AMI, CS, and polyvascular disease from the National Inpatient Sample database.
  • Stratification of patients based on diabetes status (DM vs. non-DM).
  • Multivariable logistic regression to assess in-hospital outcomes, including MACCE, mortality, CVA, and bleeding, adjusting for baseline characteristics.

Main Results:

  • 54% of the study population had DM; these patients were younger and more likely to be female.
  • Adjusted analysis revealed a 17% increased mortality risk in patients with DM (aOR 1.17, 95% CI: 1.11-1.23).
  • Patients with DM also had a higher risk of major adverse cardiovascular and cerebrovascular events (aOR 1.05, 95% CI: 1.01-1.10).

Conclusions:

  • Diabetes mellitus significantly worsens outcomes for patients with AMI, CS, and polyvascular disease.
  • DM is associated with increased mortality, longer hospital stays, and elevated healthcare costs in this population.
  • Findings emphasize the necessity for tailored interventions and specialized care strategies for high-risk patients with DM, AMI, CS, and polyvascular disease.
Abstract

Related Concept Videos

Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
762
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
908
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520